Abstract:Introduction Influenza A virus (IAV) infection predisposes to subsequent bacterial superinfection in the lungs that promotes a greater pneumonia severity. Among host innate immune players, alveolar macrophages (AM) are essential for lung protection against bacteria. From mice studies, the prominent paradigm suggests that influenza infection induces almost total mouse AM (mAM) depletion, resulting in an increased vulnerability to secondary bacterial infection. Nevertheless, the potential IAV-induced AM depletion as never been study in human. The aim of the study is to characterize the AM number in newly influenza-infected human and to compare the ability of IAV to infect AM from mouse and human origin. Methods Because the observation of AM depletion in mice was described with non-translational influenza inoculum (too high), we infected c57BL/6J mice with a mild inoculum of influenza A virus (H3N2, 10 PFU) by intranasal route and measured the AM count. Next, we described a case report of a hospital-acquired influenza infection in a patient with pre and post-infection bronchoalveolar lavage (BAL) procedures. Then, we extracted data from 2 published clinical investigations assessing BAL in critical care unit and we performed an ancillary study included patients with a PCR-confirmed influenza infection and a BAL performed within the four firth days of ICU admission (AM expressed in mean ± SEM). Finally, using ex vivo AMs models, we compared the ability of IAV to infect mouse and human AMs and the subsequence consequences regarding inflammatory mediator production. Results Using mice model of mild IAV infection, we demonstrated that despite the low IAV inoculum the AM count dropped drastically in the BAL fluid from the fourth day (reduction of 64% from baseline) and was maximal at the seventh day post-infection (reduction of 90%). At the contrary, a patient newly infected by IAV (4 days after the onset of the symptoms) did not present significant modification of the AM count (> 200,000 cells/mL before and after the IAV infection). Next, we assessed the cellularity of BAL of influenza-infected critically ill patients ( n = 15) and controls ( n = 7), thanks to the ancillary study described. The absolute AM count was respectively 3.8 × 10 5 ± 1.5 × 10 5 cells/mL in influenza-infected and 2.8 × 10 5 ± 0.6 × 10 5 cells/mL in controls. In ex vivo AM models, we demonstrated that IAV infects, replicates, and induces inflammatory response similarly in AM of mouse and human origins. Conclusion We demonstrated that IAV-induced AM depletion in mouse but not in human. We did not observe difference in vitro regarding the viral replication and subsequent inflammatory response in mAM and mAM. It is unlikely that the secondary bacterial infections are explained by AM depletion in influenza-infected human.

Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages

MLKL-Driven Inflammasome Activation and Caspase-8 Mediate Inflammatory Cell Death in Influenza A Virus Infection

Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection

The deadly dance of alveolar macrophages and influenza virus

Influenza induces depletion of alveolar macrophages in mice but not in human

Kinetics of Pulmonary Immune Cells, Antibody Responses and Their Correlations with the Viral Clearance of Influenza A Fatal Infection in Mice

Interstitial Macrophages Mediate Efferocytosis of Alveolar Epithelium During Influenza Infection

TNF Superfamily Member 14 Drives Post-Influenza Depletion of Alveolar Macrophages Enabling Secondary Pneumococcal Pneumonia

Bioinformatic analysis of PD 1 checkpoint blockade responsive immune microenvironment in severe influenza infection

Two waves of pro-inflammatory factors are released during the influenza A virus (IAV)-driven pulmonary immunopathogenesis

AIM2 Inflammasome is Critical for Influenza-Induced Lung Injury and Mortality.

Bacterial Colonization Dampens Influenza-Mediated Acute Lung Injury Via Induction of M2 Alveolar Macrophages

Influenza A virus-induced apoptosis and virus propagation

High Expression of IL-36γ in Influenza Patients Regulates Interferon Signaling Pathway and Causes Programmed Cell Death During Influenza Virus Infection

Targeting necroptosis prevents viral-induced lung damage

Osteopontin aggravates acute lung injury in influenza virus infection by promoting macrophages necroptosis

Apoptosis and Pro-inflammatory Cytokine Response of Mast Cells Induced by Influenza A Viruses

Necroptosis Restricts Influenza A Virus As a Stand-Alone Cell Death Mechanism.

Interaction among inflammasome, PANoptosise, and innate immune cells in infection of influenza virus: Updated review

Role of Nedd4L in Macrophage Pro-Inflammatory Polarization Induced by Influenza A Virus and Lipopolysaccharide Stimulation

Vagal TRPV1+ sensory neurons regulate myeloid cell dynamics and protect against influenza virus infection